Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
CSL Behring
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Men or women, at least 18 years of age, with evidence of moderate renal impairment (an eGFR ≥ 30 and \<60 mL/min/1.73 m2) and myocardial necrosis in a clinical setting consistent with a type I (spontaneous) acute myocardial infarction (AMI).
You may not be if
Symptoms, biomarker elevation or electrocardiogram (ECG) changes other than those of the index event that are consistent with a diagnosis of AMI but are likely not due to primary myocardial ischemia
Ongoing hemodynamic instability
Planned coronary artery bypass surgery
Evidence of hepatobiliary disease
History of acute kidney injury (AKI) after previous exposure to an intravenous contrast agent.
History of nephrotic range proteinuria.
Known history of allergy to soy beans or peanuts, immunoglobulin A (IgA) deficiency, antibodies to IgA , or hypersensitivity to CSL112 or any of its components.
Other severe comorbid condition, concurrent medication, or other issue that renders the subject unsuitable for participation in the study.
Clareo Health | A Study of CSL112 in Adults With Moderate Renal Impairment and Acute Myocardial Infarction
